BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 28656539)

  • 1. Medical and elective fertility preservation: impact of removal of the experimental label from oocyte cryopreservation.
    Schon SB; Shapiro M; Gracia C; Senapati S
    J Assist Reprod Genet; 2017 Sep; 34(9):1207-1215. PubMed ID: 28656539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
    Quinn MM; Cakmak H; Letourneau JM; Cedars MI; Rosen MP
    Hum Reprod; 2017 Mar; 32(3):568-574. PubMed ID: 28122888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
    Danis RB; Pereira N; Elias RT
    Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oocyte cryopreservation for fertility preservation in women with ovarian endometriosis.
    Kim SJ; Kim SK; Lee JR; Suh CS; Kim SH
    Reprod Biomed Online; 2020 Jun; 40(6):827-834. PubMed ID: 32295746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield.
    Hourvitz A; Yerushalmi GM; Maman E; Raanani H; Elizur S; Brengauz M; Orvieto R; Dor J; Meirow D
    Reprod Biomed Online; 2015 Oct; 31(4):497-505. PubMed ID: 26278808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oocyte cryopreservation review: outcomes of medical oocyte cryopreservation and planned oocyte cryopreservation.
    Walker Z; Lanes A; Ginsburg E
    Reprod Biol Endocrinol; 2022 Jan; 20(1):10. PubMed ID: 34996479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fertility Preservation for Adolescent and Young Adult Transmen: A Case Series and Insights on Oocyte Cryopreservation.
    Barrett F; Shaw J; Blakemore JK; Fino ME
    Front Endocrinol (Lausanne); 2022; 13():873508. PubMed ID: 35685214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oocyte accumulation for fertility preservation in women with benign ovarian tumours with a history of previous surgery, multiple or large cysts.
    Legrand C; Keller L; Collinet P; Barbotin AL; Béhal H; Rubod C; Decanter C
    Reprod Biomed Online; 2021 Aug; 43(2):205-214. PubMed ID: 34247989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
    Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
    Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation.
    Gunnala V; Fields J; Irani M; D'Angelo D; Xu K; Schattman G; Rosenwaks Z
    Fertil Steril; 2019 Feb; 111(2):363-371. PubMed ID: 30527950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
    Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
    Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of ovarian stimulation for oocyte cryopreservation in women with Turner syndrome.
    Talaulikar VS; Conway GS; Pimblett A; Davies MC
    Fertil Steril; 2019 Mar; 111(3):505-509. PubMed ID: 30598170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.
    Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ
    Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients' choices and benefit of the chosen methods after long-term follow up.
    Rodriguez-Wallberg KA; Marklund A; Lundberg F; Wikander I; Milenkovic M; Anastacio A; Sergouniotis F; Wånggren K; Ekengren J; Lind T; Borgström B
    Acta Obstet Gynecol Scand; 2019 May; 98(5):604-615. PubMed ID: 30723910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients.
    Goldman RH; Racowsky C; Farland LV; Munné S; Ribustello L; Fox JH
    Hum Reprod; 2017 Apr; 32(4):853-859. PubMed ID: 28166330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Oocyte and Embryo Quality Between Random Start and Controlled Ovarian Stimulation Cycles in Cancer Patients Undergoing Fertility Preservation.
    İsrafilova G; Şükür YE; Özkavukcu S; Sönmezer MA; Atabekoğlu CS; Özmen B; Berker B; Aytaç R; Koç A; Sönmezer M
    Reprod Sci; 2021 Aug; 28(8):2200-2207. PubMed ID: 33409878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type.
    Lefebvre T; Mirallié S; Leperlier F; Reignier A; Barrière P; Fréour T
    Reprod Biomed Online; 2018 Aug; 37(2):201-207. PubMed ID: 29784618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.
    Reichman DE; Davis OK; Zaninovic N; Rosenwaks Z; Goldschlag DE
    Fertil Steril; 2012 Nov; 98(5):1225-8. PubMed ID: 22884018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian stimulation is a safe and effective fertility preservation option in the adolescent and young adult population.
    Manuel SL; Moravek MB; Confino R; Smith KN; Lawson AK; Klock SC; Pavone ME
    J Assist Reprod Genet; 2020 Mar; 37(3):699-708. PubMed ID: 31828481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
    Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
    Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.